Advanced Chiropractic Equipment & Seminars Announces Venue Change for May 2026 Postgraduate Seminar in Houston

May 4, 2026 10:00 AM

Advanced Chiropractic Equipment & Seminars has announced a venue change for its upcoming Professional Postgraduate Education Seminar, scheduled to begin on May 1, 2026, in the Houston area. The seminar will now be held at the organisation's home office located in the Woodlands/Tomball area. This transition is designed to enhance the learning experience by offering more personalised, one-on-one professional training and certification...

Read more

Xcelerate Announces Agreements with Tanzanian Medical Professionals

May 4, 2026 9:25 AM

Xcelerate Inc. (OTCQB:XCRT) today announced that its majority-owned subsidiary, AfiyaSasa Africa LLC, has entered into a consulting agreement with Tanzanian medical doctor Dr. Desire Ruhinda to support the next phase of the Company's AfiyaSasa Africa initiative, while also confirming a May on-site R&D engagement led by its Chief Science Officer, Dr. Anja Glisovic.The agreement with Dr. Ruhinda marks a transition from strategic planning to...

Read more

Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health

May 4, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the planned launch of Neonorm Dog, a new extension of the Company's Neonorm franchise for companion animals. Neonorm Dog is designed to provide dog owners with access to a plant-based, non-prescription product intended to support normal stool formation, gut hydration, and bowel health in dogs. The Neonorm franchise currently includes Neonorm Foal and Neonorm Calf, plant-based products...

Read more

NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA

May 4, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that its clinical stage, broad-spectrum, antiviral drug NV-387 has been granted an "Orphan Drug Designation" (ODD) by the US FDA Office of Orphan Products Development (OOPD).The...

Read more

TailorMed and Flatiron Health Partner to Expand Medication Access and Support Across Oncology Care

May 4, 2026 8:08 AM

TailorMed, the leading medication success platform, today announced a new partnership with Flatiron Health to offer access to comprehensive medication support across Flatiron's network of oncology providers. Through this collaboration, TailorMed becomes part of the Flatiron Vendor Network, enabling practices to more easily connect patients to financial assistance, support programs, and adherence resources throughout the medication...

Read more

CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing

May 4, 2026 7:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, announced today that it has entered into securities purchase agreements for a private placement financing that is expected to result in gross proceeds of approximately $22.5 million to the Company, before placement agent fees and offering expenses.The private...

Read more

Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall

May 4, 2026 1:50 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced the nomination of a small molecule preclinical development candidate (PDC) from its multi‑target drug discovery alliance in medical dermatology with Almirall S.A. The program is aimed at developing novel treatments for immune‑mediated inflammatory skin diseases with high unmet medical need.The nomination marks an important achievement for the collaboration, with the joint team...

Read more

CMS EXPOSED: The "Workaround Doctrine" - How Matt Zorn's Legal CMS Hemp Strategy Undermines the FDA

May 3, 2026 11:30 AM

A major federal lawsuit now pending in the U.S. District Court for the District of Columbia is raising urgent questions about whether cannabinoid products can enter Medicare connected healthcare environments before they are proven safe and effective through the federal drug approval process. At the center of the dispute is:Smart Approaches to Marijuana (SAM), et al. v. Robert F. Kennedy Jr., et al.Case No. 1:26-cv-01081 (D.D.C.)The case...

Read more

Judge Hears Landmark Hemp-Marijuana Challenge to Medicare Medicaid Reimbursing Payment Program

May 2, 2026 12:15 PM

A federal district court judge in Washington, D.C. signaled significant concern Friday over whether the Centers for Medicare & Medicaid Services (CMS) exceeded its statutory authority when it launched a hemp-marijuana incentive program reimbursing cannabinoid products for Medicare beneficiaries without public rule making or FDA involvement. The program took effect on April 1, 2026. The challenge, Smart Approaches to Marijuana v. Kennedy, Civil...

Read more

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

May 1, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its manufacturing partner, Dalton Pharma Services ("Dalton"), has advanced into the next phase of intermediate-scale process development and scale-up for the Company's proprietary PNKP inhibitor technology. This next phase of work includes an expanded scale-up of precursor A83 to approximately 1,560 grams and...

Read more

Queue Ventures Announces Results of its Annual General and Special Meeting in Connection with Previously Announced Plan of Arrangement with Custom Health, Inc.

May 1, 2026 12:40 PM

Queue Ventures Ltd. ("Queue" or the "Company") is pleased to announce the results of its annual general and special meeting of holders ("Shareholders") of common shares of the Company held on April 30, 2026 (the "Meeting").Shareholders voted in favour of all resolutions presented at the Meeting, including the Company's previously announced plan of arrangement (the "Arrangement") with Custom Health, Inc. ("Custom Health"). As disclosed in the...

Read more

AI-Enabled Telehealth Access Through Independent Pharmacies

May 1, 2026 11:45 AM

Independent Pharmacy Cooperative (IPC) announces a strategic partnership with Doctronic to help independent pharmacies expand access to AI‐enabled telehealth. Building on IPC's Digital Health investments, this collaboration supports care models that prioritize convenience, speed, and trusted support close to home, while keeping pharmacies central to the patient relationship.Through this partnership, IPC and Doctronic will offer member pharmacies...

Read more

Medical Care Technologies (OTC:MDCE) Targets $100K Per Client with Real Game Used Disruptive AI Platform

May 1, 2026 9:30 AM

Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced continued advancement of its subsidiary Real Game Used's ("RGU") patent-pending artificial intelligence authentication platform, which the Company is positioning as a high-value solution for the sports memorabilia industry with a targeted offering of approximately $100,000 per client for enterprise-level access. This disruptive authentication process is anticipated to...

Read more

Tom Valentine Named President of WellBridge Surgical

May 1, 2026 9:00 AM

WellBridge Surgical is pleased to announce the appointment of Tom Valentine as President, effective April 28, 2026. Valentine brings more than 30 years of leadership experience, with a proven track record of building high-performing teams, fostering strong partnerships, and driving sustained organizational growth.Throughout his career, Valentine has developed a reputation for combining strategic vision with hands-on leadership. His experience...

Read more

MIB Agents Marks 10th Anniversary with National Day of Giving to Accelerate Osteosarcoma Breakthroughs

May 1, 2026 9:00 AM

For nearly 50 years, treatment options for osteosarcoma, a rare form of bone cancer that primarily affects children and young adults, have seen little meaningful advancement. Today, on its 10th anniversary, MIB Agents is launching a nationwide Day of Giving to help break that cycle. By partnering with patients, families, researchers, clinicians, and industry stakeholders, the nonprofit is working to transform the landscape of this disease and...

Read more

Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings

May 1, 2026 8:00 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the first quarter ended March 31, 2026 after market close on Tuesday, May 12, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a...

Read more

Securitas Healthcare Acquires ZulaFly(TM) to Advance Cloud-Based RTLS and Accelerate Innovation Across Healthcare

May 1, 2026 8:00 AM

Securitas Healthcare, a leading provider of real‑time visibility and protection solutions for the healthcare industry, is proud to announce the acquisition of ZulaFly, a healthcare‑focused Real‑Time Location System (RTLS) and staff safety technology company known for its modern, cloud‑based platform.ZulaFly's cloud-based RTLS platform delivers real-time visibility and actionable insights through a flexible, data-driven architecture. Built as a...

Read more

°MEQU Eliminates a Critical Break in Trauma Care with FDA Clearance of °M Station

May 1, 2026 7:45 AM

°MEQU today announced that its °M Station has received clearance from the U.S. Food and Drug Administration, marking a major step forward in trauma care by enabling uninterrupted blood and IV fluid warming from the point of injury through hospital treatment. In trauma care, seconds matter, and so does continuity.With the °M Warmer System, there is no device swap and no lost time. Just consistent temperature management from start to finish.The...

Read more

Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates

May 1, 2026 6:30 AM

Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the first quarter of 2026."The Moderna team delivered a great start to the year, driving significant revenue growth and substantial cost reductions building on actions taken in 2025. We received two product approvals in Europe, including the world's first flu plus COVID combination vaccine, mCOMBRIAX. We also started a new pivotal trial for...

Read more

What Is the Best Online Botox Course?

May 1, 2026 6:00 AM

As demand for aesthetic medicine training continues to grow, licensed medical professionals are comparing online Botox courses based on curriculum, instructor experience, continuing education value and access to practical clinical exposure. Among available online training options, the American Academy of Cosmetic Medicine (AACM), has emerged as a leading choice for eligible providers seeking structured online Botox and filler education for only...

Read more